Sai Life Sciences schedules earnings conference call on May 15, 2026 to discuss audited Q4 and FY26 results.
Conference call will feature management discussion and Q&A session with MD & CEO and Director & CFO.
Dial-in numbers provided for domestic and international participants with pre-registration facility available.
Disclosure made pursuant to SEBI Listing Regulations Regulation 30 for investor communication.